Kolexia
Lacour Jean Philippe Dermatologie
Lacour Jean Philippe
Dermatologie
Hôpital De l'Archet
Nice, France
504 Activités
18 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Psoriasis Mélanome Dermatite Tumeurs cutanées Eczéma atopique Épidermolyse bulleuse Métastase tumorale Urticaire Maladies de la peau

Collaborateurs

Voir plus
Passeron Thierry
Passeron Thierry
Hôpital De l'Archet, Nice, France
Bahadoran Philippe
Bahadoran Philippe
Hôpital De l'Archet, Nice, France
Montaudie Henri
Montaudie Henri
Hôpital De l'Archet, Nice, France
Chiaverini Christine
Chiaverini Christine
Hôpital De l'Archet, Nice, France

Industries

Voir plus
Lilly
25 collaboration(s)
Dernière en 2022
Sanofi
15 collaboration(s)
Dernière en 2023
Leo Pharma
7 collaboration(s)
Dernière en 2021
Novartis
6 collaboration(s)
Dernière en 2020

Dernières activités

Voir plus
Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND: An Open-label, Single-arm, Multi-centre, Long-term Extension Trial to Evaluate the Safety and Efficacy of Tralokinumab in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Clinical Trials
Essai Clinique (Leo Pharma)   06 mars 2024
EFFICACY AND SAFETY OF APREMILAST IN PATIENTS WITH MODERATE-TO-SEVERE GENITAL PSORIASIS: RESULTS FROM DISCREET, A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL.
Journal of the American Academy of Dermatology   16 octobre 2023
Role of Tyrosine Kinase Lyn and Cleaved Form by Caspases in Psoriasis
Essai Clinique (CHU Nice)   05 septembre 2023
MelBase: Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Essai Clinique (Assistance publique – Hôpitaux de Paris)   07 juillet 2023
A long-term, prospective, observational cohort study of the safety and effectiveness of etanercept for the treatment of patients with paediatric psoriasis in a naturalistic setting.
European journal of dermatology : EJD   10 mai 2023
IgE Depletion with Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients with Moderate-to-Severe Atopic Dermatitis.
The Journal of investigative dermatology   31 mars 2023
Anti-BP180 IgG antibody ELISA values correlate with adverse pregnancy outcomes in pemphigoid gestationis.
Journal of the European Academy of Dermatology and Venereology : JEADV   06 mars 2023
ECZTRA 1: A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Tralokinumab Monotherapy in Subjects With Moderate to Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy
Essai Clinique (Leo Pharma)   22 février 2023
ECZTRA 2: A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial to Evaluate the Efficacy and Safety of Tralokinumab Monotherapy in Subjects With Moderate to Severe Atopic Dermatitis Who Are Candidates for Systemic Therapy
Essai Clinique (Leo Pharma)   22 février 2023
Multicenter prospective observational study of dupilumab-induced ocular events in atopic dermatitis patients.
Journal of the European Academy of Dermatology and Venereology : JEADV   16 février 2023